ACCORDION PILL

Serial Number 79227821
Registration 5699818
700

Registration Progress

Application Filed
Nov 30, 2017
Under Examination
Approved for Publication
Jan 1, 2019
Published for Opposition
Jan 1, 2019
Registered
Mar 19, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-03-19) (Grace Period Filing)
Due: Sep 19, 2025 Grace Period - 62 days
Original deadline was Mar 19, 2025 (overdue)

Trademark Image

ACCORDION PILL

Basic Information

Serial Number
79227821
Registration Number
5699818
Filing Date
November 30, 2017
Registration Date
March 19, 2019
Published for Opposition
January 1, 2019
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 19, 2019
Registration
Registered
Classes
042

Rights Holder

Intec Pharma Ltd.

99
Address
12 Hartom Street
Jerusalem
IL

Ownership History

Intec Pharma Ltd.

Original Applicant
99
IL

Intec Pharma Ltd.

Owner at Publication
99
IL

Intec Pharma Ltd.

Original Registrant
99
IL

Legal Representation

Attorney
Susan Okin Goldsmith, Esq.

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 (6-Year) Declaration Due (Based on registration date 2019-03-19)
Due Date
March 19, 2025
Grace Period Ends
September 19, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

28 events
Date Code Type Description Documents
Mar 19, 2024 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
Aug 2, 2019 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Jul 11, 2019 FIMP P FINAL DISPOSITION PROCESSED Loading...
Jul 11, 2019 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Jun 19, 2019 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Mar 19, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 1, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 1, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 12, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 26, 2018 ALIE A ASSIGNED TO LIE Loading...
Nov 6, 2018 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 6, 2018 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Nov 6, 2018 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 6, 2018 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 6, 2018 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 22, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 25, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 24, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 24, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 13, 2018 RFNT P REFUSAL PROCESSED BY IB Loading...
Mar 27, 2018 RFRR P REFUSAL PROCESSED BY MPU Loading...
Mar 27, 2018 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Mar 21, 2018 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Mar 20, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 13, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 9, 2018 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Mar 5, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 1, 2018 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 042
Development of drug delivery systems in the nature of orally administrated capsules; development and research in the field of drug agents, pharmaceuticals and drug delivery agents
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PILL"